Tickerplace logo

Tickerplace

Pacira BioSciences, Inc. logo

PCRXPacira BioSciences, Inc.

PCRX Stock Price, Valuation & Chart | Pacira BioSciences, Inc.

Compare
$36.340+0.01 (+0.03%)

At close · 16 Oct 2026, 08:00 pm

Sector: HealthcareIndustry: Drug Manufacturers - Specialty & Generic
OverviewFinancialsDividendsRatios

PCRX Historical price chart

PCRX Key Stats

Market Capitalization1.45B
PE Ratio13.98
EPS2.6
Trading Volume960.89K
Today's High/Low36.4/36.31
Dividend Yield0.00
52 Week High/Low36.67/18.8
Shares Outstanding39.86M
PCRX Financial Statement
PCRX Analyst ratings
PCRX Analysis & performance metrics

PCRX Company profile

Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The…

PCRX Management team

Management
Susan Mesco
Head of Investor Relations
Lauren Bullaro Riker
Principal Accounting Officer & Senior Vice President of Finance
Charles A. Reinhart III, CPA, M.B.A.
Executive Officer
Anthony Molloy III, Esq.
Chief Legal & Compliance Officer
Christopher C. Young
Chief Manufacturing Officer
Kristen Williams Esq., J.D.
Chief Administrative Officer & Secretary
David M. Stack
Advisor
Jonathan Slonin M.D.
Chief Medical Officer
Total 8 executives

PCRX Frequently asked questions

What is Pacira BioSciences, Inc. (PCRX) Stock Price?

Current stock price of Pacira BioSciences, Inc. (PCRX) stock is $36.340. The stock price is +0.03% higher in the session. The intraday range can be seen from this page. Volume of Pacira BioSciences, Inc. (PCRX) stock is 960.89K.

Last updated at 16 Oct 2026, 08:00 pm.

Why is the Pacira BioSciences, Inc. (PCRX) stock price going up or down today?

The stock price of Pacira BioSciences, Inc. (PCRX) can change with earnings, company news, and overall market sentiment. Pacira BioSciences, Inc. operates in the Healthcare / Drug Manufacturers - Specialty & Generic market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Pacira BioSciences, Inc. stock expensive at its current price?

Whether Pacira BioSciences, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for PCRX on this page is 13.98. EPS on this page is 2.60. Compare those figures with peers and growth expectations before deciding if the current Pacira BioSciences, Inc. price is justified.

How has the stock price of Pacira BioSciences, Inc. (PCRX) performed historically?

Historical performance for Pacira BioSciences, Inc. (PCRX) is shown on the price chart on this page. Review multi-period moves alongside volume to see how PCRX reacted to past earnings and market events.

Should I buy Pacira BioSciences, Inc. (PCRX) stock, at this price?

Buying Pacira BioSciences, Inc. (PCRX) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.